Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Rigel Pharmaceuticals Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +3 vs. Q1 2025
- Shares held
- 13.9M
- −18.6K (−0.1%) vs. Q1 2025
- Total value
- $260.2M
- +$9.94M (+4.0%) vs. Q1 2025
- New holders
- 21
- 44 more added
- Sold out
- 18
- 36 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 155 | $640.4M |
| Q1 2026 | 159 | $432.8M |
| Q4 2025 | 194 | $690.5M |
| Q3 2025 | 169 | $425.6M |
| Q2 2025 | 126 | $260.2M |
| Q1 2025 | 123 | $250.2M |
| Q4 2024 | 122 | $203.0M |
| Q3 2024 | 93 | $192.6M |
| Q2 2024 | 91 | $85.4M |
| Q1 2024 | 117 | $164.3M |
| Q4 2023 | 113 | $154.5M |
| Q3 2023 | 106 | $114.8M |
| Q2 2023 | 118 | $142.7M |
| Q1 2023 | 125 | $148.6M |
| Q4 2022 | 118 | $163.1M |
| Q3 2022 | 138 | $150.3M |
| Q2 2022 | 135 | $157.2M |
| Q1 2022 | 163 | $405.7M |
| Q4 2021 | 162 | $365.9M |
| Q3 2021 | 163 | $499.6M |
| Q2 2021 | 160 | $614.5M |
| Q1 2021 | 152 | $493.1M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Rigel Pharmaceuticals Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen, LLC | 103,267 | $1.93M | 0.00% | −11,951−10.4% | Reduced |
| UBS Oconnor LLC | 104,890 | $1.96M | 0.05% | −5,494−5.0% | Reduced |
| Zacks Investment Management | 135,845 | $2.54M | 0.02% | +7,757+6.1% | Added |
| Northern Trust Corp | 136,496 | $2.56M | 0.00% | −5,963−4.2% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 148,183 | $2.78M | 0.01% | −9,741−6.2% | Reduced |
| Dimensional Fund Advisors LP | 155,021 | $2.90M | 0.00% | +89,721+137.4% | Added |
| Lazard Asset Management LLC | 157,000 | $2.94M | 0.00% | +22,637+16.8% | Added |
| Globeflex Capital L P | 167,515 | $3.14M | 0.26% | +115,220+220.3% | Added |
| Qube Research & Technologies Ltd | 171,424 | $3.21M | 0.00% | +16,807+10.9% | Added |
| Goldman Sachs Group Inc | 182,249 | $3.41M | 0.00% | +122,775+206.4% | Added |
| Bank of America Corp | 187,621 | $3.51M | 0.00% | +55,184+41.7% | Added |
| Jacobs Levy Equity Management, Inc | 215,633 | $4.04M | 0.02% | −2,143−1.0% | Reduced |
| Renaissance Technologies LLC | 236,446 | $4.43M | 0.01% | +35,300+17.5% | Added |
| Assenagon Asset Management S.A. | 240,005 | $4.50M | 0.01% | −282,776−54.1% | Reduced |
| CM Management, LLC | 250,000 | $4.68M | 4.26% | 00.0% | Unchanged |
| Hillsdale Investment Management Inc. | 262,064 | $4.91M | 0.18% | +69,900+36.4% | Added |
| Marshall Wace, LLP | 368,950 | $6.91M | 0.01% | +157,202+74.2% | Added |
| Geode Capital Management, LLC | 415,607 | $7.79M | 0.00% | +4,439+1.1% | Added |
| Capitolis Liquid Global Markets LLC | 591,553 | $11.1M | 0.08% | −101,547−14.7% | Reduced |
| State Street Corp | 600,181 | $11.2M | 0.00% | −36,853−5.8% | Reduced |
| Acadian Asset Management LLC | 623,004 | $11.7M | 0.02% | +57,959+10.3% | Added |
| Soleus Capital Management, L.P. | 658,145 | $12.3M | 0.85% | −472,534−41.8% | Reduced |
| Vanguard Group Inc | 1,052,871 | $19.7M | 0.00% | +24,799+2.4% | Added |
| Morgan Stanley | 1,520,217 | $28.5M | 0.00% | −16,770−1.1% | Reduced |
| Armistice Capital, LLC | 1,600,000 | $30.0M | 1.14% | +84,000+5.5% | Added |
| BlackRock, Inc. | 1,625,770 | $30.5M | 0.00% | −106,834−6.2% | Reduced |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −112,629−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −33,101−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −21,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,928−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −15,591−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −10,302−100.0% | Sold out |
| Intech Investment Management LLC | 0 | $0 | 0.00% | −10,234−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −8,527−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,930−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Laurel Wealth Advisors LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Strategic Investment Solutions, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |